Cargando…
Logic-gated antibody pairs that selectively act on cells co-expressing two antigens
The use of therapeutic monoclonal antibodies is constrained because single antigen targets often do not provide sufficient selectivity to distinguish diseased from healthy tissues. We present HexElect(®), an approach to enhance the functional selectivity of therapeutic antibodies by making their act...
Autores principales: | Oostindie, Simone C., Rinaldi, Derek A., Zom, Gijs G., Wester, Michael J., Paulet, Desiree, Al-Tamimi, Kusai, van der Meijden, Els, Scheick, Jennifer R., Wilpshaar, Tessa, de Jong, Bart, Hoff-van den Broek, Marloes, Grattan, Rachel M., Oosterhoff, Janita J., Vignau, Julie, Verploegen, Sandra, Boross, Peter, Beurskens, Frank J., Lidke, Diane S., Schuurman, Janine, de Jong, Rob N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546771/ https://www.ncbi.nlm.nih.gov/pubmed/35879362 http://dx.doi.org/10.1038/s41587-022-01384-1 |
Ejemplares similares
-
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
por: de Jong, Rob N., et al.
Publicado: (2016) -
Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
por: Oosterhoff, Janita J., et al.
Publicado: (2022) -
Antigen Geometry Tunes Mast Cell Signaling Through Distinct FcεRI Aggregation and Structural Changes
por: Rinaldi, Derek A., et al.
Publicado: (2023) -
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
por: Engelberts, Patrick J., et al.
Publicado: (2020) -
Avidity in antibody effector functions and biotherapeutic drug design
por: Oostindie, Simone C., et al.
Publicado: (2022)